[{"Assets_0_Q3_USD":"787693000.0","CIK":"1743881","CommonStockSharesConverted_0_Q3_shares":"124957091.0","CommonStockSharesOutstanding_0_Q3_shares":"122542410.0","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"-0.98","EarningsPerShareBasic_3_Q3_USD":"-2.79","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"1594164456.0","MinorityInterest_0_Q3_USD":"52057000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"-303453000.0","NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":"-115859000.0","NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":"-328743000.0","OfficialName":"BridgeBio Pharma Inc. Common Stock","ProfitLoss_1_Q3_USD":"-130167000.0","ProfitLoss_3_Q3_USD":"-370463000.0","RevenuesConverted_1_Q3_USD":"8127000.0","RevenuesConverted_3_Q3_USD":"8127000.0","SP500":null,"Sector":"Health Care","StockholdersEquityConverted_0_Q3_USD":"215813000.0","StockholdersEquity_0_Q3_USD":"163756000.0","Ticker":"BBIO","filed":"20201105","footnote":null,"form":"10-Q","fp":"Q3","fy":"2020.0","name":"BRIDGEBIO PHARMA, INC.","period":"20200930","qtrs":"0","uom":"USD"}]